USD 1.92
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 1.83 Million | 1.62 Million | -6.45 Million | 1.29 Million | -4.6 Million | -527.66 Thousand |
Net Income | 532.4 Thousand | 806.13 Thousand | 876.32 Thousand | 687.4 Thousand | 493.69 Thousand | 359.1 Thousand |
Depreciation & Amortization | 154.11 Thousand | 139.12 Thousand | 137.11 Thousand | 134.65 Thousand | 147.95 Thousand | 127.09 Thousand |
Deferred income taxes | -102.83 Thousand | 58.83 Thousand | -87 Thousand | -10 Thousand | 77 Thousand | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 60.53 Thousand | -157.62 Thousand | -8.49 Million | -40.13 Thousand | -5.88 Million | -1.54 Million |
Other non-cash items | -11.02 Million | 778.24 Thousand | 1.02 Million | 514.77 Thousand | 643 Thousand | 2.21 Million |
Investing Cash Flow | -12.3 Million | -3.62 Million | -80.5 Thousand | -62.29 Thousand | -246.71 Thousand | -194.69 Thousand |
Investments in PPE | -62.71 Thousand | -48.74 Thousand | -36.92 Thousand | -21.89 Thousand | -16.34 Thousand | -18.61 Thousand |
Acquisitions | 18.51 Thousand | 4500.00 | - | - | 4000.00 | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -12.26 Million | -3.57 Million | -43.57 Thousand | -40.39 Thousand | -234.36 Thousand | -176.08 Thousand |
Financing Cash Flow | 10.09 Million | 2.39 Million | 6.07 Million | -1.1 Million | 5.11 Million | 131.98 Thousand |
Debt repayment | -10.21 Million | -536.78 Thousand | -103.29 Thousand | -643 Thousand | -505.7 Thousand | -131.98 Thousand |
Dividends payments | -116.2 Thousand | -89.19 Thousand | -69.3 Thousand | -48.97 Thousand | -94.14 Thousand | - |
Common Stock Repurchased | - | - | - | -320 Thousand | - | - |
Common Stock Issuance | - | 400 Thousand | - | 320 Thousand | - | - |
Other Financing Activities | 20.43 Million | 2.62 Million | 6.24 Million | -410.74 Thousand | 5.71 Million | - |
Accounts receivables | -12.21 Million | -3.53 Million | -8.51 Million | -597.58 Thousand | -5.42 Million | -1.66 Million |
Accounts payables | 237.34 Thousand | -194.82 Thousand | 302.26 Thousand | 376.49 Thousand | 35.44 Thousand | 237.38 Thousand |
Inventory | 12.21 Million | - | 8.51 Million | 597.58 Thousand | 5.42 Million | - |
Other working capital | -176.81 Thousand | 3.57 Million | -8.79 Million | -416.63 Thousand | -5.92 Million | -114.43 Thousand |
Cash at beginning of period | 421.21 Thousand | 20.98 Thousand | 477.28 Thousand | 345.6 Thousand | 77.56 Thousand | 667.93 Thousand |
Cash at end of period | 45.23 Thousand | 421.21 Thousand | 20.98 Thousand | 477.29 Thousand | 345.6 Thousand | 77.56 Thousand |
Capital Expenditure | -62.71 Thousand | -48.74 Thousand | -36.92 Thousand | -21.89 Thousand | -16.34 Thousand | -18.61 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -375.97 Thousand | 400.22 Thousand | -456.3 Thousand | 131.68 Thousand | 268.04 Thousand | -590.37 Thousand |
Free Cash Flow | 1.76 Million | 1.57 Million | -6.48 Million | 1.27 Million | -4.61 Million | -546.27 Thousand |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 327.45 Thousand | 118.8 Thousand | 532.4 Thousand | 170.55 Thousand | 116.93 Thousand | 176.04 Thousand |
Depreciation & Amortization | 39.91 Thousand | 41.26 Thousand | 154.11 Thousand | 39.05 Thousand | 38.97 Thousand | 38.22 Thousand |
Deferred income taxes | - | -21 Thousand | -102.83 Thousand | -102.83 Thousand | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -235.69 Thousand | -225.5 Thousand | 60.53 Thousand | -32.52 Thousand | 194.29 Thousand | 477 Thousand |
Other non-cash items | 497.91 Thousand | 74.31 Thousand | -11.02 Million | 345.83 Thousand | 319.96 Thousand | 190.49 Thousand |
Investing Cash Flow | -4.71 Million | -4.74 Million | -12.3 Million | -1.34 Million | -4.28 Million | -3.93 Million |
Investments in PPE | -600.00 | -26.66 Thousand | -62.71 Thousand | -53.59 Thousand | -1773.00 | -7348.00 |
Acquisitions | - | - | 18.51 Thousand | 18.51 Thousand | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -4.71 Million | -4.72 Million | -12.26 Million | -1.31 Million | -4.28 Million | -3.92 Million |
Financing Cash Flow | 4.27 Million | 4.53 Million | 10.09 Million | 867.94 Thousand | 3.46 Million | 2.93 Million |
Debt repayment | -4.27 Million | -4.56 Million | -10.21 Million | -965.77 Thousand | -75.78 Thousand | -447.96 Thousand |
Dividends payments | - | -29.05 Thousand | -116.2 Thousand | -29.05 Thousand | -29.05 Thousand | -29.05 Thousand |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | 3.23 Million | 20.43 Million | 1.86 Million | 3.57 Million | 3.41 Million |
Accounts receivables | - | -4.71 Million | -12.21 Million | -12.21 Million | - | - |
Accounts payables | -106.57 Thousand | 240.76 Thousand | 237.34 Thousand | 71.26 Thousand | -8265.00 | 37.9 Thousand |
Inventory | - | - | 12.21 Million | - | - | - |
Other working capital | -129.12 Thousand | -466.27 Thousand | -176.81 Thousand | -103.78 Thousand | 202.55 Thousand | 439.1 Thousand |
Cash at beginning of period | 1144.00 | 45.23 Thousand | 421.21 Thousand | - | 147.8 Thousand | 260.49 Thousand |
Cash at end of period | 1044.00 | 1144.00 | 45.23 Thousand | 45.23 Thousand | - | 147.8 Thousand |
Capital Expenditure | -600.00 | -26.66 Thousand | -62.71 Thousand | -53.59 Thousand | -1773.00 | -7348.00 |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -100.00 | -44.09 Thousand | -375.97 Thousand | 45.23 Thousand | -147.8 Thousand | -112.69 Thousand |
Free Cash Flow | 442.58 Thousand | 140.44 Thousand | 1.76 Million | 469.32 Thousand | 668.38 Thousand | 874.41 Thousand |
CONFRZ
KRTA
PROSY
AOVTF
PIIIW
ML